These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1925168)

  • 21. Individual bioequivalence: what matters to the patient.
    Hauck WW; Anderson S
    Stat Med; 1991 Jun; 10(6):959; discussion 959-60. PubMed ID: 1876785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bioequivalence assessment of pioglitazone hydrochloride oral preparation by limited sampling strategy].
    Ding JJ; Jiao Z; Li ZD; Shi XJ
    Yao Xue Xue Bao; 2006 Sep; 41(9):893-8. PubMed ID: 17111840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An approach to select the appropriate statistical method for testing bioequivalence.
    Steyn HS; Koeleman HA; Gouws E; Ritschel WA
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):156-60. PubMed ID: 1822089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
    Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
    Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of bioequivalence using a multiplicative model.
    Chow SC; Peace KE; Shao J
    J Biopharm Stat; 1991; 1(2):193-203. PubMed ID: 1844696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective assessment of the 75/75 rule in bioequivalence.
    Dobbins TW; Thiyagarajan B
    Stat Med; 1992 Jul; 11(10):1333-42. PubMed ID: 1518994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A three-step procedure for assessing bioequivalence in the general mixed model framework.
    Vuorinen J; Turunen J
    Stat Med; 1996 Dec; 15(24):2635-55. PubMed ID: 8981677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The subject-by-formulation interaction in multivariate bioequivalence.
    Cao L; Mathew T
    J Biopharm Stat; 2007; 17(3):367-79. PubMed ID: 17479387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consideration of individual bioequivalence.
    Anderson S; Hauck WW
    J Pharmacokinet Biopharm; 1990 Jun; 18(3):259-73. PubMed ID: 2380920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scale effect in bioequivalence evaluations.
    Wang Y; Eradiri O; Odidi I; Geng W; Odidi A; Muhuri G
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):534-9. PubMed ID: 9799057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.
    Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A
    Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biometrical evaluation of bioequivalence trials using a bootstrap individual direct curve comparison method.
    Zintzaras E; Bouka P; Kowald A
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):11-6. PubMed ID: 11996322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
    Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study on the bioequivalence of two formulations of pravastatin. Data from a crossover, randomised, open-label bioequivalence study in healthy volunteers.
    Almeida S; Filipe A; Almeida A; Gich I; Antonijoan R; Puntes M; Barbanoj M; Cruz Caturla M
    Arzneimittelforschung; 2006; 56(2):70-5. PubMed ID: 16572920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Types of bioequivalence and related statistical considerations.
    Hauck WW; Anderson S
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PhRMA perspective on population and individual bioequivalence.
    Barrett JS; Batra V; Chow A; Cook J; Gould AL; Heller AH; Lo MW; Patterson SD; Smith BP; Stritar JA; Vega JM; Zariffa N
    J Clin Pharmacol; 2000 Jun; 40(6):561-70. PubMed ID: 10868305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers.
    Kim SH; Park YS; Kim JM; Park HJ; Lee MH; Park HK; Kim YJ; Cho SH; Shaw LM; Kang JS
    Int J Clin Pharmacol Ther; 2012 Jul; 50(7):524-31. PubMed ID: 22541755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.